Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(902)
•••
Post by CommonCentsforDollarson Dec 06, 2020 3:57pm
300 Views
Post# 32046561

Natalie Pace: House Decriminalizes Cannabis

Natalie Pace: House Decriminalizes Cannabishttps://www.nataliepace.com/blog/house-decriminalizes-cannabis-pot-stocks-triple-off-low


Aphria
Aphria purchased Sweetwater Brewing Company (based in Atlanta) in December of 2020. Sweetwater’s 420 Strain G13 IPA became the #1 bestselling new craft beer of 2019 (according to the company). Currently the brew includes terpenes and hemp flavors. However, it’s easy to see that the branding and flavors position the company as a leader for a cannabis-legal world (and are doing quite well even now). The acquisition price was $300 million and should add at least $67 million annually to the revenue of Aphria. Sweetwater sells at Walgreens and Duane Reade in Manhattan, at Walmart and Winn Dixie in Miami and even at gas stations in Atlanta.
 
Aphria’s CEO is Irwin Simon, the founder and former CEO and chairman of Hain Celestial. Walter Robb, the former co-CEO of Whole Foods, is on the Aphria board. Don’t be surprised if you see Sweetwater Beverages in a Whole Foods store near you soon.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities